Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BIOLASE, Inc. stock logo
BIOL
BIOLASE
$0.01
+21.8%
$0.01
$0.02
$1.94
$581K0.672.58 million shs14,555 shs
Cutera, Inc. stock logo
CUTR
Cutera
$0.04
-63.9%
$0.04
$0.09
$1.87
$787K1.362.68 million shs27.70 million shs
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
$0.36
+16.4%
$3.51
$0.30
$24.00
$160K1.121.47 million shs67.79 million shs
Sonendo, Inc. stock logo
SONX
Sonendo
$1.15
$1.25
$1.00
$19.94
$493K1.51,027 shs2 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BIOLASE, Inc. stock logo
BIOL
BIOLASE
+21.30%+21.30%+7.31%+50.51%-91.35%
Cutera, Inc. stock logo
CUTR
Cutera
0.00%0.00%0.00%0.00%-97.61%
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
+16.38%-67.54%-92.51%-94.25%-97.59%
Sonendo, Inc. stock logo
SONX
Sonendo
0.00%+4.55%-24.34%-32.35%+1,085.57%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BIOLASE, Inc. stock logo
BIOL
BIOLASE
N/AN/AN/AN/AN/AN/AN/AN/A
Cutera, Inc. stock logo
CUTR
Cutera
N/AN/AN/AN/AN/AN/AN/AN/A
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
0.6198 of 5 stars
0.02.00.00.02.90.80.6
Sonendo, Inc. stock logo
SONX
Sonendo
1.0026 of 5 stars
0.05.00.00.02.20.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BIOLASE, Inc. stock logo
BIOL
BIOLASE
3.00
Buy$1.2010,652.69% Upside
Cutera, Inc. stock logo
CUTR
Cutera
2.50
Moderate Buy$3.007,592.31% Upside
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
2.00
HoldN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BIOLASE, Inc. stock logo
BIOL
BIOLASE
$48.83M0.01N/AN/A($0.07) per share-0.16
Cutera, Inc. stock logo
CUTR
Cutera
$155.21M0.01N/AN/A($8.62) per share0.00
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
$520K0.37N/AN/A$4.26 per share0.08
Sonendo, Inc. stock logo
SONX
Sonendo
$44.40M0.01N/AN/A$89.42 per share0.01
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BIOLASE, Inc. stock logo
BIOL
BIOLASE
-$20.63M-$14.94N/AN/A-41.65%-1,782.73%-55.31%8/6/2025 (Estimated)
Cutera, Inc. stock logo
CUTR
Cutera
-$162.83M-$6.58N/AN/AN/A-84.86%N/A-45.07%8/6/2025 (Estimated)
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
-$11.74M-$47.53N/AN/A-3,010.14%-418.82%-243.54%8/11/2025 (Estimated)
Sonendo, Inc. stock logo
SONX
Sonendo
-$60.92M-$59.12N/AN/A-92.74%-184.01%-68.60%8/8/2025 (Estimated)

Latest HSDT, CUTR, SONX, and BIOL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2025Q1 2025
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
-$0.58-$0.51+$0.07-$0.51N/A$0.05 million
3/25/2025Q4 2024
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
-$14.10-$15.45-$1.35-$1.03$0.10 million$0.15 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BIOLASE, Inc. stock logo
BIOL
BIOLASE
N/AN/AN/AN/AN/A
Cutera, Inc. stock logo
CUTR
Cutera
N/AN/AN/AN/AN/A
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
N/AN/AN/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BIOLASE, Inc. stock logo
BIOL
BIOLASE
N/A
0.71
0.36
Cutera, Inc. stock logo
CUTR
Cutera
N/A
2.88
1.86
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
N/A
1.69
1.13
Sonendo, Inc. stock logo
SONX
Sonendo
0.55
1.82
1.22

Institutional Ownership

CompanyInstitutional Ownership
BIOLASE, Inc. stock logo
BIOL
BIOLASE
8.79%
Cutera, Inc. stock logo
CUTR
Cutera
90.70%
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
18.63%
Sonendo, Inc. stock logo
SONX
Sonendo
28.68%

Insider Ownership

CompanyInsider Ownership
BIOLASE, Inc. stock logo
BIOL
BIOLASE
0.27%
Cutera, Inc. stock logo
CUTR
Cutera
0.42%
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
17.90%
Sonendo, Inc. stock logo
SONX
Sonendo
7.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
BIOLASE, Inc. stock logo
BIOL
BIOLASE
16033.41 million33.32 millionNot Optionable
Cutera, Inc. stock logo
CUTR
Cutera
46020.19 million20.10 millionOptionable
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
30530,000433,000Not Optionable
Sonendo, Inc. stock logo
SONX
Sonendo
250429,000393,000Not Optionable

Recent News About These Companies

Sonendo Inc.
Sonendo, Inc. (SONX) Q2 2024 Earnings Call Transcript
Here's what Wall Street expects from Sonendo's earnings report
Sonendo, Inc. (SONX)

New MarketBeat Followers Over Time

Media Sentiment Over Time

BIOLASE stock logo

BIOLASE NASDAQ:BIOL

$0.01 +0.00 (+21.83%)
As of 06/17/2025

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

Cutera stock logo

Cutera NASDAQ:CUTR

$0.04 -0.07 (-63.86%)
Closing price 03/12/2025
Extended Trading
$0.04 0.00 (0.00%)
As of 03/12/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and Enlighten SR/III, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides Excel HR, a hair removal solution for all skin types; xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity; and Secret DUO, two dual non-ablative fractional technologies that can be used individually or in combination to target a variety of aesthetic concerns and skin conditions on all skin types with little to no downtime. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.

Helius Medical Technologies stock logo

Helius Medical Technologies NASDAQ:HSDT

$0.36 +0.05 (+16.38%)
Closing price 06/18/2025 04:00 PM Eastern
Extended Trading
$0.37 +0.01 (+2.69%)
As of 06/18/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

Sonendo stock logo

Sonendo NYSE:SONX

$1.15 0.00 (0.00%)
As of 06/17/2025

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.